95 related articles for article (PubMed ID: 24092353)
1. Pulmonary hypertension: novel pathways and emerging therapies inhibitors of cGMP and cAMP metabolism.
Sassi Y; Hulot JS
Handb Exp Pharmacol; 2013; 218():513-29. PubMed ID: 24092353
[TBL] [Abstract][Full Text] [Related]
2. Reduction of cAMP and cGMP inhibitory effects in human platelets by MRP4-mediated transport.
Borgognone A; Pulcinelli FM
Thromb Haemost; 2012 Nov; 108(5):955-62. PubMed ID: 23014861
[TBL] [Abstract][Full Text] [Related]
3. Inhibition of MRP4 prevents and reverses pulmonary hypertension in mice.
Hara Y; Sassi Y; Guibert C; Gambaryan N; Dorfmüller P; Eddahibi S; Lompré AM; Humbert M; Hulot JS
J Clin Invest; 2011 Jul; 121(7):2888-97. PubMed ID: 21670499
[TBL] [Abstract][Full Text] [Related]
4. Multi-drug resistance protein 4 (MRP4)-mediated regulation of fibroblast cell migration reflects a dichotomous role of intracellular cyclic nucleotides.
Sinha C; Ren A; Arora K; Moon CS; Yarlagadda S; Zhang W; Cheepala SB; Schuetz JD; Naren AP
J Biol Chem; 2013 Feb; 288(6):3786-94. PubMed ID: 23264633
[TBL] [Abstract][Full Text] [Related]
5. Initial biochemical and functional characterization of cyclic nucleotide phosphodiesterase isozymes in canine colonic smooth muscle.
Barnette MS; Manning CD; Price WJ; Barone FC
J Pharmacol Exp Ther; 1993 Feb; 264(2):801-12. PubMed ID: 7679736
[TBL] [Abstract][Full Text] [Related]
6. Cyclic nucleotide compartmentalization: contributions of phosphodiesterases and ATP-binding cassette transporters.
Cheepala S; Hulot JS; Morgan JA; Sassi Y; Zhang W; Naren AP; Schuetz JD
Annu Rev Pharmacol Toxicol; 2013; 53():231-53. PubMed ID: 23072381
[TBL] [Abstract][Full Text] [Related]
7. MRP4-mediated regulation of intracellular cAMP and cGMP levels in trabecular meshwork cells and homeostasis of intraocular pressure.
Pattabiraman PP; Pecen PE; Rao PV
Invest Ophthalmol Vis Sci; 2013 Mar; 54(3):1636-49. PubMed ID: 23385799
[TBL] [Abstract][Full Text] [Related]
8. Cyclic nucleotide phosphodiesterase (PDE) inhibitors: novel therapeutic agents for progressive renal disease.
Cheng J; Grande JP
Exp Biol Med (Maywood); 2007 Jan; 232(1):38-51. PubMed ID: 17202584
[TBL] [Abstract][Full Text] [Related]
9. Increased expression of the cGMP-inhibited cAMP-specific (PDE3) and cGMP binding cGMP-specific (PDE5) phosphodiesterases in models of pulmonary hypertension.
Murray F; MacLean MR; Pyne NJ
Br J Pharmacol; 2002 Dec; 137(8):1187-94. PubMed ID: 12466227
[TBL] [Abstract][Full Text] [Related]
10. Effects of various phosphodiesterase-inhibitors, forskolin, and sodium nitroprusside on porcine detrusor smooth muscle tonic responses to muscarinergic stimulation and cyclic nucleotide levels in vitro.
Truss MC; Uckert S; Stief CG; Kuczyk M; Schulz-Knappe P; Forssmann WG; Jonas U
Neurourol Urodyn; 1996; 15(1):59-70. PubMed ID: 8696357
[TBL] [Abstract][Full Text] [Related]
11. Cyclic AMP and cyclic GMP suppress TNFalpha-induced hepatocyte apoptosis by inhibiting FADD up-regulation via a protein kinase A-dependent pathway.
Wang Y; Kim PK; Peng X; Loughran P; Vodovotz Y; Zhang B; Billiar TR
Apoptosis; 2006 Mar; 11(3):441-51. PubMed ID: 16538385
[TBL] [Abstract][Full Text] [Related]
12. Lowered cAMP and cGMP signalling in the brain during levodopa-induced dyskinesias in hemiparkinsonian rats: new aspects in the pathogenetic mechanisms.
Giorgi M; D'Angelo V; Esposito Z; Nuccetelli V; Sorge R; Martorana A; Stefani A; Bernardi G; Sancesario G
Eur J Neurosci; 2008 Sep; 28(5):941-50. PubMed ID: 18717735
[TBL] [Abstract][Full Text] [Related]
13. Sildenafil treatment in vivo stimulates Leydig cell steroidogenesis via the cAMP/cGMP signaling pathway.
Andric SA; Janjic MM; Stojkov NJ; Kostic TS
Am J Physiol Endocrinol Metab; 2010 Oct; 299(4):E544-50. PubMed ID: 20663985
[TBL] [Abstract][Full Text] [Related]
14. Phosphodiesterase II, the cGMP-activatable cyclic nucleotide phosphodiesterase, regulates cyclic AMP metabolism in PC12 cells.
Whalin ME; Scammell JG; Strada SJ; Thompson WJ
Mol Pharmacol; 1991 Jun; 39(6):711-7. PubMed ID: 1646946
[TBL] [Abstract][Full Text] [Related]
15. Effect of restricted food intake on production, catabolism, and effects of IGF-I and cyclic nucleotides in cultured ovarian tissue of domestic nutria (Myocastor coypus).
Sirotkin AV; Mertin D; Süvegová K; Makarevich AV; Genieser HG; Luck MR; Osadchuk LV
Gen Comp Endocrinol; 2000 Feb; 117(2):207-17. PubMed ID: 10642443
[TBL] [Abstract][Full Text] [Related]
16. Cross talk between NO and cyclic nucleotide phosphodiesterases in the modulation of signal transduction in blood vessel.
Lugnier C; Keravis T; Eckly-Michel A
J Physiol Pharmacol; 1999 Dec; 50(4):639-52. PubMed ID: 10639014
[TBL] [Abstract][Full Text] [Related]
17. Modulation of rat thymocyte proliferative response through the inhibition of different cyclic nucleotide phosphodiesterase isoforms by means of selective inhibitors and cGMP-elevating agents.
Marcoz P; Prigent AF; Lagarde M; Nemoz G
Mol Pharmacol; 1993 Nov; 44(5):1027-35. PubMed ID: 8246905
[TBL] [Abstract][Full Text] [Related]
18. PDE and cognitive processing: beyond the memory domain.
Heckman PR; Blokland A; Ramaekers J; Prickaerts J
Neurobiol Learn Mem; 2015 Mar; 119():108-22. PubMed ID: 25464010
[TBL] [Abstract][Full Text] [Related]
19. Cross-regulation of intracellular cGMP and cAMP in cultured human corpus cavernosum smooth muscle cells.
Kim NN; Huang Y; Moreland RB; Kwak SS; Goldstein I; Traish A
Mol Cell Biol Res Commun; 2000 Jul; 4(1):10-4. PubMed ID: 11152621
[TBL] [Abstract][Full Text] [Related]
20. A photoaffinity probe covalently modifies the catalytic site of the cGMP-binding cGMP-specific phosphodiesterase (PDE-5).
Corbin JD; Beasley A; Turko IV; Haik TL; Mangum KA; Wells JN; Francis SH; Sekhar KR
Cell Biochem Biophys; 1998; 29(1-2):145-57. PubMed ID: 9631243
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
